AvalehtSNYNF • OTCMKTS
add
Sanofi SA
Viimane sulgemishind
95,50 $
Aasta vahemik
90,45 $ - 119,65 $
Turuväärtus
124,10 mld USD
Keskmine maht
759,00
P/E suhe
-
Dividendimäär
-
Põhibörs
EPA
Uudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
(EUR) | sept 2024info | Y/Y muutus |
---|---|---|
Käive | 14,16 mld | 11,49% |
Põhitegevusega seonduv kulu | 5,99 mld | 11,39% |
Puhastulu | 2,82 mld | 11,49% |
Puhaskasumimarginaal | 19,88 | −0,05% |
Puhaskasum aktsia kohta | 1,54 | −39,43% |
EBITDA | 4,91 mld | 15,96% |
Tõhus maksumäär | 20,58% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
(EUR) | sept 2024info | Y/Y muutus |
---|---|---|
Sularaha ja lühiajalised investeeringud | 6,80 mld | −14,99% |
Kogu vara | — | — |
Kõik kohustused | — | — |
Kogu omakapital | 73,00 mld | — |
Emiteeritud aktsiate arv | 1,25 mld | — |
Hinna ja väärtuse suhe P/B | 1,64 | — |
Varade tasuvus | — | — |
Kapitali tasuvus | 10,54% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
(EUR) | sept 2024info | Y/Y muutus |
---|---|---|
Puhastulu | 2,82 mld | 11,49% |
Põhitegevuse rahakäive | — | — |
Investeeringute raha | — | — |
Finantseerimise raha | — | — |
Raha ja raha ekvivalentide muutus | — | — |
Tasuta rahavoog | — | — |
Teave
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
Tegevjuht
Asutatud
1973
Peakontor
Veebisait
Töötajate arv
86 088